William Blair Initiates Coverage on Campbell's (NASDAQ: CPB) with 'Market Perform' Rating

Font: Financial Modeling Prep  • Jun 23, 2026

• Analyst firm William Blair has initiated a 'Market Perform' rating on Campbell's (NASDAQ: CPB), indicating expected stock performance in line with the broader market.
• The investment rating acknowledges significant operational challenges for the food company, including declining gross and operating margins and inefficient asset utilization.
• Despite these issues, Campbell's is actively pursuing product innovation, expanding its Meals & Beverages portfolio with new offerings like a gluten-free chicken noodle soup to adapt to evolving consumer preferences.

Analyst firm William Blair initiates coverage on Campbell's (NASDAQ: CPB) with a Market Perform rating. Campbell's is a well-known food company with a history of nearly 150 years, famous for its soups and other food products. The rating suggests the stock is expected to perform in line with the broader market, reflecting both challenges and positive developments in the consumer goods sector.

This neutral rating considers significant operational challenges. As highlighted by Seeking Alpha, one analysis notes that Campbell's structural problems are serious. The company's gross and operating margins, which measure profitability from sales and core operations, have been declining. This trend appears to be getting worse, with inefficient asset usage leading to performance below its peers in the food industry.

Despite these issues, Campbell's is adapting to changing consumer preferences, as noted by Zacks. The company is expanding its Meals & Beverages portfolio through product innovation. For the first time in its long history, it has launched a gluten-free version of its iconic chicken noodle soup to attract new customers and broaden its market appeal.

This new product, highlighted by Business Wire, is a partnership with Banza, a top better-for-you pasta brand. It uses Banza's chickpea pasta, making a classic soup available to gluten-free consumers. This is part of a plan to increase spending on brand support and product innovation to grow its appeal and strengthen its market position.

On the day of the rating, Campbell's stock price was priced at $20.40, down 3.55%. The stock's 52-week range is between $19.56 and $34.17. The company has a market capitalization, or total value of all its shares, of approximately $6.08 billion with a trading volume over 11.6 million shares, providing key investment metrics for potential investors.